Stay updated on PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page metadata was updated from v3.5.4 to v3.5.5, indicating a new release of the page. This update does not modify study data, results, or visible content.
    Difference
    0.0%
    Check dated 2026-06-08T03:54:20.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The revision tag changed from v3.5.3 to v3.5.4, indicating a new release version. This update records the deployment change and does not alter the page’s substantive content or data.
    Difference
    0.0%
    Check dated 2026-05-17T10:01:18.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Updated the ClinicalTrials.gov page build/version indicator from “Revision: v3.5.2” to “Revision: v3.5.3.” This reflects a site update rather than a change to the underlying trial record history.
    Difference
    0.0%
    Check dated 2026-04-25T18:44:12.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Added revision label v3.5.2 to the history and removed the v3.5.0 entry.
    Difference
    0.0%
    Check dated 2026-04-18T13:35:53.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 to the page history. Removed Revision: v3.4.3 from the history.
    Difference
    0.0%
    Check dated 2026-03-21T00:44:49.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    Added revision: v3.4.3 and removed revision: v3.4.2 from the Record History.
    Difference
    0.0%
    Check dated 2026-03-06T18:36:24.000Z thumbnail image

Stay in the know with updates to PF-06463922 ALK/ROS1 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PF-06463922 ALK/ROS1 Inhibitor Clinical Trial page.